DIARTIS PHARMACEUTICALS

diartis-pharmaceuticals-logo

Diartis Pharmaceuticals, Inc. is a privately held biopharmaceutical company with headquarters in Mountain View, CA. Diartis Pharmaceuticals was formed to concentrate on the development of novel therapeutic proteins for the treatment of metabolic disorders. In December 2010, Diartis Pharmaceuticals acquired the VRS-859 program from Versartis, Inc.

#SimilarOrganizations #People #Financial #Website #More

DIARTIS PHARMACEUTICALS

Industry:
Biotechnology Health Care Life Science Pharmaceutical

Founded:
2010-01-01

Address:
Mountain View, California, United States

Country:
United States

Website Url:
http://www.diartispharma.com

Total Employee:
1+

Status:
Closed

Contact:
650-963-8595

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Domain Not Resolving


Similar Organizations

citron-pharma-logo

Citron Pharma

Citron Pharma is a privately held pharmaceutical company.

harkness-pharmaceuticals-logo

Harkness Pharmaceuticals

Harkness Pharmaceuticals is a privately-held development stage biopharmaceutical company.

neosil-logo

Neosil

Neosil is a dermatology focused pharmaceutical company.


Current Advisors List

not_available_image

Mark Kipnes clinical advisor @ Diartis Pharmaceuticals
Advisor

Founder


jeffrey-cleland_image

Jeffrey Cleland

Investors List

index-ventures_image

Index Ventures

Index Ventures investment in Venture Round - Diartis Pharmaceuticals

Official Site Inspections

http://www.diartispharma.com

Unable to get host informations!!!

Loading ...

More informations about "Diartis Pharmaceuticals"

Diartis Pharmaceuticals - Crunchbase Company Profile …

Diartis Pharmaceuticals, Inc. is a privately held biopharmaceutical company with headquarters in Mountain View, CA. Diartis Pharmaceuticals was formed to …See details»

Diartis Pharmaceuticals Inc - Company Profile and News

Company profile page for Diartis Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»

DIARTIS PHARMACEUTICALS - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for DIARTIS PHARMACEUTICALS of Redwood City, CA. Get the latest business insights from Dun & …See details»

Diartis Pharmaceuticals - CoBee Company Profile & Funding Rounds

Diartis Pharmaceuticals, Inc. is a privately held biopharmaceutical company with headquarters in Mountain View, CA. Diartis Pharmaceuticals was formed to concentrate on the development of …See details»

Diartis Pharmaceuticals Company Profile | Management and

Find contact information for Diartis Pharmaceuticals. Learn about their Manufacturing market share, competitors, and Diartis Pharmaceuticals's email format.See details»

Diartis Pharmaceuticals - PitchBook

When was Diartis Pharmaceuticals founded? Diartis Pharmaceuticals was founded in 2010. Who is the founder of Diartis Pharmaceuticals? Jeffrey Cleland Ph.D is the founder of Diartis …See details»

Diartis Pharmaceuticals - VentureRadar

Diartis Pharmaceuticals VentureRadar profile. Find out more about Diartis Pharmaceuticals, Healthtech and Life Sciences.See details»

Diartis Pharmaceuticals | VentureRadar

Molecular Imaging USA Privately Held Molecular Imaging, Inc. is a specialty contract research organization (CRO) located in Ann Arbor, Michigan. Molecular Imaging employs a wide array …See details»

Diartis Pharmaceuticals - Tech Company Profile - Gaebler.com …

Funded Tech Companies Diartis Pharmaceuticals. Diartis Pharmaceuticals is a biopharmaceutical tech venture, based in Redwood City. Financial backing was provided by Index Ventures and …See details»

Diartis Pharmaceuticals Inc. Asset Profile | Preqin

Founded in 2010 and based in Mountain View, California, Diartis Pharmaceuticals Inc. is a biopharmaceutical company and it develops therapeutic proteins for ...See details»

Diartis Pharmaceuticals - Products, Competitors, Financials, …

Feb 16, 2011 Further information on Diartis can be found at www.diartispharma.com. About Index Ventures Index Ventures is a leading global venture capital firm active in technology …See details»

Diartis Pharmaceuticals - Company Profile - Tracxn

Diartis Pharmaceuticals - R&D of therapeutic proteins to treat metabolic disorders. This company is not active anymore. Raised funding over 1 round from 2 investors. Diartis Pharmaceuticals …See details»

Diartis Pharmaceuticals Company Profile -Sales, Contacts, …

Diartis Pharmaceuticals is in the Pharmaceuticals industry within the Wholesale Trade - Nondurable Goods sector and has been in business for approximately 12 years.See details»

Diartis Pharmaceuticals - Contacts, Employees, Board Members, …

Diartis Pharmaceuticals is a privately held biopharmaceutical company.See details»

Index Ventures and Amunix, Inc. Invest in New Company, Diartis ...

Feb 16, 2011 New compounds developed by Diartis using the XTEN technology are expected to provide improved therapeutic outcomes such as enhanced efficacy/compliance, fewer side …See details»

Index Ventures And Amunix Invest In Diartis Pharmaceuticals

New Biotech Company Will Focus on Clinical Development of Novel Diabetes Drug. Mountain View, CA (Marketwire) - Diartis Pharmaceuticals, Inc., a newly founded biotechnology …See details»

Diartis Pharmaceuticals Reviews | Read Client Reviews of Diartis ...

Read reviews of Diartis Pharmaceuticals. Write and share your personal story. Your experience will help others make the right buying decision.See details»

Diartis, Inc.' Positive Clinical Results of VRS-859 for Type

Jun 11, 2012 PHILADELPHIA, PA--(Marketwire - June 09, 2012) - Diartis Pharmaceuticals, Inc. today presented positive data from its recently completed Phase 1 multicenter clinical trial of …See details»

Diartis Presents VRS-859 Positive Clinical Results for Type 2 …

Oct 2, 2012 Diartis Pharmaceuticals, Inc. is presenting positive data from its completed Phase 1 multicenter clinical trial of VRS-859 at the European Association for the Study of Diabetes 48th …See details»

Diartis, Inc. Presents VRS-859 Positive Clinical Results for

Oct 2, 2012 BERLIN--(Marketwire - October 02, 2012) - Diartis Pharmaceuticals, Inc. is presenting positive data from its completed Phase 1 multicenter clinical trial of VRS-859 …See details»

linkstock.net © 2022. All rights reserved